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Background: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that is thought to be a precursor
to most invasive and metastatic breast cancers. Understanding the mechanisms regulating the invasive transition of
DCIS is critical in order to better understand how some types of DCIS become invasive. While significant insights have
been gained using traditional in vivo and in vitro models, existing models do not adequately recapitulate key structure
and functions of human DCIS well. In addition, existing models are time-consuming and costly, limiting their use in
routine screens. Here, we present a microscale DCIS model that recapitulates key structures and functions of human DCIS,
while enhancing the throughput capability of the system to simultaneously screen numerous molecules and drugs.
Methods: Our microscale DCIS model is prepared in two steps. First, viscous finger patterning is used to generate
mammary epithelial cell-lined lumens through extracellular matrix hydrogels. Next, DCIS cells are added to fill the
mammary ducts to create a DCIS-like structure. For coculture experiments, human mammary fibroblasts (HMF) are added
to the two side channels connected to the center channel containing DCIS. To validate the invasive transition of the DCIS
model, the invasion of cancer cells and the loss of cell-cell junctions are then examined. A student t-test is conducted for
statistical analysis.
Results: We demonstrate that our DCIS model faithfully recapitulates key structures and functions of human mammary
DCIS and can be employed to study the mechanisms involved in the invasive progression of DCIS. First, the formation of
cell-cell junctions and cell polarity in the normal mammary duct, and the structure of the DCIS model are characterized.
Second, coculture with HMF is shown to induce the invasion of DCIS. Third, multiple endpoint analyses are
demonstrated to validate the invasion.
Conclusions: We have developed and characterized a novel in vitro model of normal and DCIS-inflicted mammary
ducts with 3D lumen structures. These models will enable researchers to investigate the role of microenvironmental
factors on the invasion of DCIS in more in vivo-like conditions.
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Ductal carcinoma in situ (DCIS) is a non-invasive form
of breast cancer that originates and is confined to the
lumen of the mammary duct [1,2]. Even though DCIS
itself is non-invasive, there has been a dramatic increase
in the reporting of DCIS due to the enhancement in im-
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unless otherwise stated.screenings. It is known that some cases of DCIS will
never become invasive; however, roughly 30% of DCIS
cases will progress to IDC within 10 years of diagnosis if
left untreated [3]. Recent studies have shown that the
DCIS and IDC share similar risk factors and present
similar gene expression patterns. This makes it nearly
impossible to distinguish which DCIS cases are more
aggressive and will progress to IDC based on genetics
alone [4]. This inability to distinguish indolent from
aggressive DCIS results in a clinical dilemma balancing
the potential benefits of reducing the risk of a future in-
vasive breast cancer versus the risks of unnecessaryThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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crine therapy [5,6].
Due to the risks associated with overdiagnosis and
overtreatment of DCIS patients, there is increased interest
in studying which factors promote the invasive transition
of DCIS to IDC. To this end, several in vitro and in vivo
models of DCIS have been developed. The MINO (mam-
mary intraepithelial outgrowth) mouse model and the
MIND (mammary intraductal) mouse model are promis-
ing in vivo models of DCIS. In the MINO model, mice
have been engineered to have neoplastic outgrowths from
mammary ducts [7,8] while in the MIND model, human
DCIS cell lines are transplanted intraductally to mimic the
structure of DCIS found in humans [9,10]. The in vivo
models such as these are more physiologically relevant
and allow us to investigate the influence of various micro-
environmental factors because the models use a whole or-
ganism. However, in vivo models can be time-consuming
and expensive, limiting their use in routine screens inves-
tigating potential factors capable of promoting the invasive
transition of DCIS. In addition, the use of mouse models
often presents ethical issues and, more importantly, the
mouse mammary microenvironment does not faithfully
recapitulate the human mammary microenvironment
[11]. For instance, human breast tissue has more fibrous
connective tissue and less adipocytes than mouse mam-
mary tissue.
Various in vitro culture models have been introduced
to investigate the effect of microenvironmental factors
on the fate of DCIS cells. First, model cell lines have
been developed to look at the influence of molecular
changes in the breast cancer tumor microenvironment
in vitro [12,13]. Second, traditional 3D macroscale
models in multi-wells or transwells incorporating 3D
extracellular matrix (ECM) and coculture with other cell
types have been developed and used to investigate the
effects of the ECM and interactions between tumor cells
and stromal cells on invasion [13,14]. Third, with the
advancement in microscale technology, microscale 3D
DCIS models have also been recently developed. Micro-
scale models enhance functionality and efficiency while
maintaining key attributes of their macroscale counter-
parts. By taking advantage of microfabrication technology,
the geometry of the microsystem is varied to enhance
temporal and spatial controls [15,16]. In fact, a recent mi-
croscale 3D model developed to investigate the invasive
progression of DCIS revealed the importance of the
distance between cancer cells and fibroblasts as well as
the presence of heterogeneous contact between cancer
cells and fibroblasts in regulating the invasive progression
of DCIS [15]. While these models have made important
advances, there is a lack of models with physiologically
relevant lumen structures which have been shown to in-
fluence cell behavior [17-19]. Additionally, recent evidencesupports the ability of in vitro tissue structure to influence
the behavior of other cell types and the outcome of
biological studies [19]. For instance, using micro-tissue
patterns, Nelson et al. have found that tissue geometry de-
termines the sites of mammary branching morphogenesis
due to the distribution of secreted factors and mechanical
stresses [20]. In addition, it was shown that culturing epi-
thelial cells in different 2D patterns and initialing EMT
influences the spatial pattern of EMT [21]. Based on the
influences of tissue geometry observed in these examples,
it is important to develop in vitro models with improved
physiologically relevant tissue structure in order to com-
plement and overcome the limitations inherent in current
in vivo and in vitro models and improve researchers’ abil-
ity to effectively study mechanisms governing the invasive
transition of DCIS.
Here, we present a novel 3D in vitro mammary duct
model with physiologically relevant lumen structures.
Taking our cue from the MIND mouse model described
above, we have developed a DCIS model by filling the
mammary duct models with DCIS cells in order to study
the effects of microenvironmental factors on the invasive
transition of DCIS. Using a viscous finger patterning
method [22,23], lumen structures are patterned with a
double-layered ECM hydrogel consisting of a collagen I
outer layer with a Matrigel inner layer to model the
basement membrane. The lumens are lined with a non-
cancerous human mammary epithelial cell line, MCF10a,
to model a normal mammary duct. To model a mammary
duct with DCIS, MCF10aDCIS.com cells (MCF10a-de-
rived DCIS cell line) are pipetted into the lumen of the
in vitro mammary duct where they grow and fill the
lumen. Because our system provides a more in vivo-like
structure of DCIS (i.e., a mammary epithelial cell-lined
lumen filled with cancer cells), the DCIS cells present a
more in vivo-like invasive transition when the cancer cells
are cocultured with stromal fibroblasts. In traditional
methods, cancer cells are cultured from a single cell and
form elongated clusters when they become invasive. How-
ever, in our system, the mammary duct already contains
numerous cancer cells which then invade from the duct
out into the stroma, much like they would in vivo. The
viscous fingering method enables users to easily pattern
lumen structures through ECM hydrogels in microchan-
nels using only a micropipette, is highly compatible with




Polydimethylsiloxane (PDMS, Sylgard 184 Silicone Elasto-
mer Kit, Dow Corning, Midland, MI) elastomer base and
curing agent were mixed at a 10:1 ratio and degassed
for 45 minutes under vacuum at room temperature. The
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that were generated using standard soft lithography
methods [24]. PDMS was cured at 80 degrees Celsius for
4 hours. Single and triple (Figure 1) microchannel geom-
etries that have been previously described [23] were used
in these experiments depending on the application. Briefly,
single microchannels have a width of 500 μm, height of
500 μm, and length of 5 mm with inlet and outlet ports
on each end. Triple microchannels consist of three single
microchannels connected by smaller diffusion channels
that are 100 μm in height, 400 μm in width and 500 μm
in length.
Cell culture
Human mammary epithelial cells (MCF10a) were ob-
tained from ATCC (Manassas, VA, USA) and maintainedFigure 1 Schematic overview of model patterning methods. As
previously described, a lumen can be patterned through a collagen I
hydrogel in the center chamber of a triple microchannel using
viscous finger patterning [22]. The collagen I lumen is then coated
with a Matrigel lining. Following polymerization, MCF10a cells are
used to line the lumen and mimic a mammary duct structure. HMF
cells in a collagen I hydrogel can be added to the side chambers. To
model DCIS, MCF10aDCIS.com cells are flowed into the lumen
after 24 hours.with DMEM/F12 medium (Invitrogen, Carlsbad, CA,
USA) supplemented with 5% horse serum (Invitrogen,
Carlsbad, CA, USA), 20 ng/ml epidermal growth factor
(EGF, Peprotech, Oak Park, CA, USA), 0.5 mg/ml hydro-
cortisone (Sigma-Aldrich, St. Louis, MO, USA), 100 ng/ml
cholera toxin (Sigma-Aldrich, St. Louis, MO, USA), 10 μg/
ml insulin (Sigma-Aldrich, St. Louis, MO, USA) and 1%
Pen/Strep (Invitrogen, Carlsbad, CA, USA) on regular tis-
sue culture flasks. MCF10a-DCIS.com (MCF10aDCIS)
cells were obtained from Asterand (Detroit, MI, USA) and
maintained in DMEM/F12 medium (Invitrogen, Carlsbad,
CA, USA) supplemented with 5% horse serum (Invitrogen,
Carlsbad, CA, USA) and 1% Pen/Strep (Invitrogen,
Carlsbad, CA, USA) on regular tissue culture flasks. Hu-
man mammary fibroblasts (HMFs) were obtained from Dr.
Charlotte Kuperwasser (originally located at Whitehead
Institute for Biomedical Research, Nine Cambridge Center,
Cambridge, MA) and maintained in DMEM supplemented
with 10% fetal bovine serum (FBS, Invitrogen, Carlsbad,
CA, USA) and 1% Pen/Strep (Invitrogen, Carlsbad, CA,
USA) on regular tissue culture flasks [25].
Hydrogel preparation
For lumen patterning as well as for culturing fibroblasts,
a hydrogel consisting of ECM proteins made of a final
concentration of 6.0 mg/ml Type I collagen (rat tail, BD
Biosciences, Bedford, MA, USA. To make roughly 125 μl
of hydrogel solution, 1.56 μl of a basic solution (5.0 N
NaOH), 20 μl of culture medium and 25 μl of 5X PBS was
added to 78 μl of the collagen I and incubated on ice for a
period between 5–10 minutes to apply an additional
nucleation phase [26]. These volumes were scaled up to
prepare the amount of hydrogel solution needed for a
given experiment. Matrigel (BD Biosciences, Bedford, MA,
USA) was also used as a coating material (described in
detail below).
Lumen patterning
Prior to patterning lumens, devices were oxygen-plasma-
treated to bond the PDMS channels to a glass surface (the
inside of a glass-bottom Petri dish, MatTek, Ashland, ME,
USA), and to render the inside of the chambers hy-
drophilic. The devices were coated with 100 μg/ml FN to
facilitate adhesion of the hydrogel to the channel walls.
After 20 min incubation at room temperature, the FN
solution was aspirated from the channel. To pattern a
lumen through a hydrogel in a single microchannel, vis-
cous finger patterning was used as previously described
[22]. Briefly, viscous finger patterning is performed by dis-
pensing 5 μl of a pre-polymerized hydrogel solution into a
microchannel. Then a small droplet of a low viscosity fluid
(roughly 2 μl of culture medium) is dispensed through the
hydrogel solution via surface tension-based passive pump-
ing (i.e. fluid flows from the inlet port to the outlet port
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ences in viscosity, when the less viscous medium flows
through the channel, it pushes through the more viscous
hydrogel solution in a finger-like pattern leaving behind a
medium-filled lumen in the hydrogel. After incubating the
hydrogel in the microchannels for 10 min at 37°C, poly-
merization of the hydrogel is completed, resulting in a pat-
terned lumen through a hydrogel. In these experiments an
outer layer of 6.0 mg/ml Collagen I was patterned. After
10 min incubation at 37°C, Matrigel was added to the
lumen and viscous fingering was performed again to pat-
tern a lumen through this inner layer.
For coculture experiments, a single lumen in the center
channel of a triple microchannel was patterned, leaving
the two side channels open. Lumen patterning was
achieved by the method described in Figure 1.Mammary epithelial cell seeding
To line the lumen with MCF10as and generate a normal
mammary duct model, a cell solution was prepared at
50,000-60,000 cells/μl and 2 μl were added to the lu-
mens. With the lid of the Petri dish securely attached,
the dish containing the microchannels was taped to the
rod that is attached to a motor (BBQ Rotisserie Variable
Speed Reversible Brushless Gear Motor, Wondermotor,
CA, USA). This motor was placed inside an incubator at
37 degrees Celsius and tuned to rotate the dishes at 2
RPM for 30 minutes to allow cell attachment. After this
procedure, channels were righted and incubated at 37
degrees Celsius for a minimum of 2 hours before being
perfused with fresh medium via passive pumping to
rinse unattached cells.DCIS cell seeding
To generate the DCIS model, lumens were first lined with
MCF10a cells and cultured overnight at 37 degrees Cel-
sius. Then, 2 μl of a cell solution with 50,000 MCF10aD-
CIS cells/μl was added to the lumens. With the lid of the
Petri dish securely attached, the dish containing the
microchannels was taped to the rod that is attached to a
motor (BBQ Rotisserie Variable Speed Reversible Brush-
less Gear Motor, Wondermotor, CA, USA). This motor
was placed inside an incubator at 37°C and tuned to rotate
the dishes at 2 RPM for 30 minutes to enable cells to
attach evenly throughout the lumen. Alternatively, it is
possible to achieve an even layer of cells by manually
rotating the dish by 90 degrees every 15 minutes, reseed-
ing cells into the channel between each rotation [23]. After
this procedure, channels were incubated at 37 degrees
Celsius for roughly 2 hours, rinsed with fresh medium to
remove unattached cells and incubated at 37 degrees
Celsius over night. In control experiment, MCF10a cells
replaced the DCIS cells to fill the lumens.HMF cell seeding for DCIS invasion experiments
To assess the ability of fibroblasts to induce the invasive
transition of DCIS to IDC, the DCIS lumen models were
patterned in the center channel of a tri-channel device
and cocultured with fibroblasts in both of the side chan-
nels. 24 hours after the addition of MCF10as lining the
lumens, a solution with a final concentration of 6.0 mg/ml
collagen I and 6,000 HMF cells/μl was added to the side
channels. The MCF10aDCIS cells were then added as pre-
viously described. Control channels with MCF10a cells
alone, MCF10a cells with HMFs and the DCIS lumen
model (MCF10a lining with MCF10aDCIS cells) alone
were also patterned. Bright-field images were collected
daily for a period of 5 days to assess invasion of the mam-
mary duct and DCIS lumen models.
Cell staining
To confirm that MCF10a cells formed monolayers coating
the entire lumen, and that the cells were forming cadherin
junctions, mammary ducts were cultured for 48 h,
fixed with 4% paraformaldehyde (PFA) (Fisher Scientific,
Hampton, NH, USA), and stained for e-cadherin. Models
were blocked with 3% BSA, immunolabeled with mouse
anti-human e-cadherin antibodies (5 μg/ml, BD Biosci-
ences, Bedford, MA, USA), and fluorescently labeled with
AlexaFlour 488 (10 μg/ml, anti-mouse, Molecular Probes,
Eugene, OR, USA). Hoechst 33342 (10 μg/ml, Molecular
Probes) was used to stain the nuclei. To confirm that the
MCF10a cells were properly polarizing in the mammary
ducts, cells were cultured for 72 hours, fixed and blocked
as previously described. The cells were then stained for
basement membrane protein laminin-5 (10 μg/ml, mouse,
human specific, AbCam, Cambridge, MA, USA), apical
marker GM130 (10 μg/ml, rabbit, AbCam, Cambridge,
MA, USA) and nuclei (Hoechst 33342). The laminin was
fluorescently labeled with AlexaFlour 488 (10 μg/ml, anti-
mouse, Molecular Probes, Eugene, OR, USA) and the
GM130 was fluorescently labeled with AlexaFlour 647
(10 μg/ml, anti-rabbit, Molecular Probes, Eugene, OR,
USA). To visualize the DCIS lumen model, MCF10a cells
were stained with green cell tracker dye (10 μM, Life
Technologies, Grand Island, NY, USA) and MCF10aDCIS
cells were stained with blue cell tracker dye (10 μM, Life
Technologies, Grand Island, NY, USA) for 30 minutes
prior to each respective cell seeding. The channels were
then fixed after 72 hours as previously described. For
multiphoton laser scanning microscopy and second
harmonic generation imaging, cells were visualized by
staining for filamentous actin using Alexa Flour 594 phal-
loidin (10 μg/ml, Invitrogen).
Image acquisition
Fluorescently labeled samples were imaged using an
A1RSi confocal microscope (Nikon Instruments, Tokyo,
Figure 2 Mammary duct model with 3D lumen structure. A)
Volume-rendered confocal image of MCF10a cells lining a lumen
patterned through a collagen I hydrogel and coated with Matrigel.
Cells were cultured for 72 hours and then stained for e-cadherin
(red) and nuclei (blue). Scale bar represents 50 μm. B) Confocal slice
of bottom of the lumen to show e-cadherin localization around cell
junctions. Scale bar represents 5 μm. C) Volume-rendered confocal
image of MCF10a cells lining a lumen and stained for laminin V
(green), nuclei (blue) and GM130 (red) to demonstrate cell
polarization. Scale bar represents 1 μm.
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Advanced software (Nikon). Images files were converted
using Fiji software, and volume-rendered images were
generated using OsiriX. Bright-field images were col-
lected with an Olympus IX70 microscope (Center Valley,
PA, USA) and acquired using MetaMorph 7.5 (Mole-
cular Devices, LLC, Sunnyvale, CA, USA). Multiphoton
laser scanning microscopy (MPLSM) imaging was per-
formed on an Optical Workstation that was constructed
around a Nikon Eclipse TE300. A MaiTai Deepsee Ti:
sapphire laser (Spectra Physics, Mountain View, CA)
excitation source tuned to 890 nm was used. The beam
was focused onto the sample with a Nikon (Mehlville,
NY) 10X SuperFluor air-immersion lens (numerical
aperture (NA) = 0.5). All SHG imaging was detected from
the back-scattered SHG signal with a H7422 GaAsP
photomultiplier detector (Hamamatsu, Bridgewater, NJ),
and the presence of collagen was confirmed by filtering
the emission signal with a 445 nm (narrow-band pass)
filter (TFI Technologies, Greenfield, MA) to isolate
the SHG signal. Images were acquired using WiscScan
(http://www.loci.wisc.edu/software/wiscscan), a laser scan-
ning software acquisition package developed at LOCI
(Laboratory for Optical and Computational Instrumenta-
tion, University of Wisconsin, Madison, WI) described in
previous work [15].
Invasion experiment analysis
To investigate invasiveness bright field images of three
independent experiments were analyzed manually using
ImageJ for invasion frequency and area of invasive le-
sions. The entire length of the microchannel was ana-
lyzed and the ports were excluded. A Student’s t-test
was used to determine significant differences between
samples. P-values less than 0.05 were considered to be
significant. To analyze collagen modification from the
SHG images, the average intensity of a 20 pixel region
extending from the cell-ECM boundary was measured
using ImageJ. The intensity of regions surrounding the
non-invasive cells were compared to the region surround-
ing the invasive cells.
Results and discussion
Lumen-based in vitro mammary duct model
A microfluidic model of a normal mammary duct with a
physiologically relevant lumen structure was developed
as a foundation for a lumen-based DCIS model. To
generate the model, viscous finger patterning [22,23]
was used to pattern a lumen through a double-layered
hydrogel consisting of an outer layer of collagen I and
an inner layer of Matrigel to represent the basement
membrane. Briefly, microchannels with two ports open
to the air are filled with a pre-polymerized solution of
collagen I. Surface tension-driven pumping (i.e. passivepumping) is used to flow a droplet of a culture medium
from the inlet port to the outlet port [27]. Due to
the differences in viscosity between the hydrogel and
the medium, the medium flows through the center of the
channel patterning a lumen through the hydrogel [22].
Following polymerization of the collagen gel, Matrigel is
flowed into the lumen and rinsed with culture media to
model the basement membrane and provide a thin coating
and provide proteins, such as laminin and collagen IV, re-
quired for normal epithelial cell polarization [28]. After
polymerization of the Matrigel, lumens were then lined
with MCF10a cells, a non-cancerous human mammary
epithelial cell line (Figure 1). We found that the presence
of the basement membrane in our system enhanced the
attachment of MCF10a cells as well as the formation of a
confluent monolayer in the lumen and polarization of
the cells. While there are other methods to pattern
lumen structures through ECM hydrogels for modeling
mammary ducts [20] or other structures with lumen
geometries (i.e. vessels) [29,30], the use of viscous finger
patterning offers several advantages. This technique is
easy to perform and requires only the use of a micropip-
ette, making this technique accessible for widespread
use. Additionally, this technique can be performed with
automated liquid handling systems and scaled up into
high-throughput screening arrays [31,32].
The formation of adherens junctions between neighbor-
ing cells and proper apico-basal cell polarity are essential
for normal epithelial organization [33-35]. To confirm that
our mammary duct model was demonstrating proper
junction formation cells were stained for a known epithe-
lial cell junction marker, e-cadherin (Figure 2A-B). The
MCF10A cells in our channel showed adherens junctions
throughout the lumen structure. To confirm that the
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the cells were cultured for 72 hours and stained for an
apical polarity marker, GM130, and a basal polarity
marker, laminin-5. As shown in the Figure 2C, the apical
golgi markers were facing inward toward the inside of the
hollow lumen and the basal marker were facing outward.
A human specific antibody was used for laminin-5 to en-
sure that the laminin was produced by the MCF10a cells
and not part of the mouse-derived Matrigel. This was
confirmed by staining an unlined lumen with the same
antibody; no cross-reactivity was detected. It has been
reported that MCF10a cell lines do not usually form tight
junctions, reaching an incomplete differentiation stage
[36]. Thus, we did not stain for the formation of tight
junctions in our model.
Modeling Ductal Carcinoma in situ
To better mimic the DCIS structure found in vivo we
used the model of the normal mammary duct as the
foundation. Following MCF10a cell seeding, epithelium
was cultured for 24 hours before pipetting MCF10aDCIS
cells into the lumens (Figure 1). Figure 3 shows confocal
images of the DCIS model 48 hours after MCF10aDCIS
cell seeding where the non-neoplastic MCF10a cells
were labeled with cell tracker green and the MCF10aD-
CIS cells were labeled with cell tracker blue. Comple-
mentary to recent in vitro mammary duct models which
focus on studying the initiation of mammary tumors
within the mammary duct from small groups of cancer
cells [35,37], we have used a high number of DCIS cells
in order to mimic a more advanced stage of DCIS, simi-
lar to the MIND mouse model that has been previously
developed [10]. The MCF10aDCIS cell line was derived
as a model of comedo-type DCIS [12], and it was ob-
served that the MCF10a cells completely filled the center
of the lumen. This is similar in structure to comedo-type
DCIS found in humans.
Evidence suggests that the invasive progression of
DCIS to IDC is strongly influenced by alterations in theFigure 3 To model ductal carcinoma in situ MCF10aDCIS.com
cells were added to the center of MCF10alined lumens after
24 hours. Volume-rendered (A) and confocal slice (B) images are
shown. Cells were stained with cell tracker green (MCF10a) and cell
tracker blue (MCF10DCIS.com) and cultured for 72 hours after the
addition of the DCIS cells. Scale bars represent 100 μm.surrounding stromal cells and extracellular matrix
[16,38,39]. To show that our model can be used to study
such paracrine interactions, we have cocultured our
DCIS model with human mammary fibroblasts (HMF),
stromal cells that have been shown to induce the inva-
sive transition in our previous work by Sung et al. [15].
This cell line was isolated from fibrocystic tissue and is
not tumorigenic [25]. However, protein expression pro-
filing shows that the expression pattern of these cells
overlaps to some degree with the pattern of cancer-
associated mammary fibroblasts [40]. For the coculture
experiments, we used a system containing three larger
microchannels connected by smaller diffusion channels
[23]. The physical separation by diffusion channels sim-
plified the loading process and also provided more
in vivo-like cell organization by putting stromal fibro-
blasts next to mammary ducts. We have previously
shown that diffusion channels between two cell com-
partments enabled paracrine cell signaling [19,23]. As
shown in Figure 4, when the DCIS model (MCF10a-
lined lumen with DCIS in the center) was patterned in
the center channel of a tri-channel device and cocul-
tured with HMFs in the side channels, invasion into the
surrounding ECM was observed after 5 days. No inva-
sion was observed when the normal mammary duct
model (MCF10a-lined lumen) is cocultured with fibro-
blasts or when the DCIS lumen model is cultured alone.
In control experiments, where MCF10a cells were added
to the center of MCF10a-lined lumens in place of the
DCIS cells, no invasion was observed in monoculture or
in coculture with HMFs. Additionally, when DCIS cells
were used to line the lumens in place of MCF10a cells, a
confluent monolayer failed to form. We were able to
count the number of invasive lesions per channel as well
as per area, showing higher numbers of lesions in cocul-
ture to determine the invasiveness (Figures 4C and D).
The invasive transition of DCIS in our lumen-based
model was validated by multiple endpoint analyses. First,
the invasive transition was analyzed by estimating the
average number (Figure 4C) and area (Figure 4D) of in-
vasive lesions sprouting out from the main lumen filled
with DCIS cells, more similar to the measurement con-
ducted for the transition in vivo. Second, the loss of
adherens junctions in invasive MCF10aDCIS cells was
examined. In cells undergoing transition from an epithe-
lial to a more invasive cell type decreased e-cadherin
levels are often observed [40]. When stained for e-cadherin,
cells that have begun to invade into the surrounding matrix
along the edge of the DCIS lumen model showed the
decreased expression of e-cadherin compared to non-
invading cells in the center (Figure 5). Third, we have
also examined the changes in collagen architecture
around MCF10aDCIS cells invading into stroma. Previ-
ous work has demonstrated that ECM alterations (i.e.,
Figure 4 Coculture with HMF induces invasive transition in the DCIS model. A) Schematic image of coculture experiments with the DCIS
model in the center chamber of a triple microchannel and HMFs in the side chambers. B) Bright-field images of mammary duct, mammary duct
filled with MCF10a cells, and mammary duct filled with DCIS cells either alone or in coculture with HMFs. Scale bars represent 100 μm (main chart) and
50 μm (close up image at the right). The average number (C) and area (D) of invasive lesions in the different culture conditions were quantified across
three independent experiments with at least three channels per experiment. A student Student’s t-test was used to determine significant differences
between culture conditions (p < 0.05 is considered to be significant).
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fiber angles) are associated with increased breast cancer
invasion [15,41]. Accordingly, we used multi-photon
and second harmonic generation (SHG) imaging to in-
vestigate collagen I modifications around invasive DCIS
lesions in our model. SHG is widely used to analyze the
properties of ECM because the intensity of SHG is
proportional to the density of collagen [15,42]. The
compartmentalized fashion of our microsystem allows
the imaging and analysis of the collagen structure asso-
ciated with each cell type in coculture while minimizing
inference from other cell types [15]. The SHG intensity
in Figure 6 is approximately 2.5 times greater around
the invasive DCIS lesion (indicated by the “high collagen
modification” region) compared to the SHG intensity
along the non-invasive region (indicated by the “low colla-
gen modification” region) of the DCIS lumen model. Thisincreased intensity indicates increased collagen I modifica-
tion around the invasive lesion [15]. When performing
SHG imaging, the power and gain were set so that the
areas with “high collagen modification” would not be
oversaturated, causing the areas with “no collagen modifi-
cation” have a very low SHG intensity. SHG intensity was
estimated using ImageJ. In future work, SHG imaging can
be used to further investigate changes in collagen density
and fiber alignment [41].
Here, we have developed and characterized an in vitro
model of DCIS within a ductal structure and observed
the effects of fibroblasts on invasion. The phenotype of
invasive transition observed in the lumen system is
analogous to the invasive phenotype observed in humans
[43], in which cancer cells invade out from the mam-
mary duct into the surrounding stroma. In contrast to
common analysis methods of measuring the size and
Figure 5 Invasive lesions show decreased e-cadherin. Schematic (A) and confocal slice (B-D) of bottom of DCIS model cocultured with HMFs
for 5 days and stained for e-cadherin (red) and nuclei (blue). A magnified view of a less invasive region (C) compared to a more invasive region
(D) indicate that e-cadherin is down regulated in cells that have undergone the invasive transition. Scale bars represent 50 μm.
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of single cells, the quantification of lesion size from a
duct-like structure is analogous to the quantification of
tumor size and invasive margins used in humans [44].
Additionally, in vivo mouse studies of DCIS usually in-
volve growing DCIS cells in the mammary fat pad
[45,46], but cells are not limited to the ducts as in the
MINO and MIND model. Together, these in vitro and
in vivo methods have provided valuable insight into the
signaling mechanisms involved in invasive transition.
Our in vitro DCIS model with lumen-like structures will
be a useful complementary model to currently availablesystems by providing a greater ability to isolate specific
interactions than in vivo models and using techniques
that are amenable for high-throughput screening when
interfaced with automated pipetting systems [22,31,32].
This model enables myriad other studies looking at mi-
croenvironmental effects. In the present study we used
collagen I and Matrigel, but it is possible to incorporate
other ECM molecules, such as laminin-111 known for
inducing epithelail call polarization [47], into the colla-
gen itself or as a lumen coating [22,32,48]. Investigation
of the relationship between DCIS and other stromal cell
types, such as macrophages or adipocyte, is also possible
Figure 6 Second Harmonic Generation (SHG) imaging of
collagen modifications by invasive clusters. Multiphoton image
of a DCIS model cocultured with HMFs. Cells were stained with
phalloidin to mark f-actin (shown in red). Using SHG imaging we are
able to identify increased collagen I (show in white) modification
near the invasive region compared to non-invasive regions. Scale
bar represents 100 μm.
Bischel et al. BMC Cancer  (2015) 15:12 Page 9 of 10in future work. Finally, the microchannel design used in
this work has been previously used to study the effects
of growth factor gradients on a microvessel model [23]
and may enable the use of this model to investigate the
influence of chemical gradients on DCIS invasion.
Conclusions
In this study we have developed novel in vitro models of
a normal mammary duct with physiologically relevant
patterned lumen structures. By filling the lumens with
DCIS cells we have developed a model to study the inva-
sive transition of DCIS in response to microenvironmen-
tal factors. These models have 3D lumen geometries
which are physiologically relevant and have been previ-
ously demonstrated to influence cell behavior. The vis-
cous finger patterning method used in the generation of
these models is user-friendly, requires only a micropip-
ette to perform, and can be scaled up into large screen-
ing arrays using automated pipeting systems. Using this
model of DCIS, we have demonstrated the ability to
study the effects of HMFs and potentially other micro-
environmental factors on the invasive transition of DCIS
to IDC in a physiologically relevant in vitro setting. In
future work, this platform can be expanded to study the
role of other stromal cell types, ECM molecules, chem-
ical gradients, and drug treatment. In addition, our mi-
croscale platform has significantly reduced the numberof cells required for each endpoint, ultimately allowing
multiple candidate biomarkers to be screened simultan-
eously with primary cells isolated from small biopsies
from patients.
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